Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Guangzhou Jet Bio-Filtration Co Ltd
Total Current Liabilities
Guangzhou Jet Bio-Filtration Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Guangzhou Jet Bio-Filtration Co Ltd
SSE:688026
|
Total Current Liabilities
¥119m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
23%
|
CAGR 10-Years
13%
|
|
|
S
|
Shanghai Conant Optical Co Ltd
HKEX:2276
|
Total Current Liabilities
¥421.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Total Current Liabilities
¥2.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Total Current Liabilities
¥5.3B
|
CAGR 3-Years
36%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Total Current Liabilities
¥908.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
24%
|
CAGR 10-Years
23%
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Total Current Liabilities
¥19.1B
|
CAGR 3-Years
119%
|
CAGR 5-Years
60%
|
CAGR 10-Years
N/A
|
|
Guangzhou Jet Bio-Filtration Co Ltd
Glance View
Guangzhou Jet Biofiltration Co., Ltd. engages in the research and development, manufacture, and sale of biological laboratory consumables. The company is headquartered in Guangzhou, Guangdong and currently employs 1,431 full-time employees. The company went IPO on 2020-01-22. The firm focuses on disposable plastic consumables for cell culture and related liquid handling biological laboratories. Its main products include biological culture type and liquid handling type, as well as reagents and small laboratory equipment. The firm distributes its products in domestic and to overseas markets.
See Also
What is Guangzhou Jet Bio-Filtration Co Ltd's Total Current Liabilities?
Total Current Liabilities
119m
CNY
Based on the financial report for Dec 31, 2024, Guangzhou Jet Bio-Filtration Co Ltd's Total Current Liabilities amounts to 119m CNY.
What is Guangzhou Jet Bio-Filtration Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
13%
Over the last year, the Total Current Liabilities growth was 16%. The average annual Total Current Liabilities growth rates for Guangzhou Jet Bio-Filtration Co Ltd have been -6% over the past three years , 23% over the past five years , and 13% over the past ten years .
